GlassScriptPhysician profile
Danny Binh Luong
NPI 1386750438
$6,251.09
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,557 · 2020: $819 · 2021: $1,236 · 2022: $431 · 2023: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $208.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $1,542.77 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $593.91 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $538.29 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $528.21 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $492.54 | 2019-2021 | |
| Allergan, INC. | $442.01 | 2019-2021 | |
| Eyevance Pharmaceuticals LLC | $325.63 | 2019-2021 | |
| Alcon Vision LLC | $319.72 | 2019-2023 | Rhopressa, Rocklatan, Simbrinza |
| Oyster Point Pharma, INC. | $234.98 | 2022 | |
| Kala Pharmaceuticals, INC. | $175.01 | 2020-2021 | |
| Carl Zeiss Meditec, INC. | $162.55 | 2019 | |
| Sight Sciences, INC. | $162.12 | 2021 | |
| Biotissue Holdings INC. | $147.28 | 2020-2023 | |
| Regeneron Healthcare Solutions, INC. | $142.36 | 2019 | |
| Iridex Corporation | $94.71 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $59.76 | 2022-2023 | Alrex, Prolensa, Lotemax Sm |
| Shire North American Group INC | $59.30 | 2019 | |
| Ivantis, INC | $45.15 | 2020-2021 | |
| Horizon Therapeutics Plc | $41.29 | 2022 | |
| Omeros Corporation | $32.67 | 2019 | |
| Dompe US, INC. | $24.81 | 2021 | |
| Beaver-Visitec International, INC. | $23.39 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Alimera Sciences, INC. | $18.90 | 2019 | |
| Glaukos Corporation | $15.19 | 2022 | |
| New World Medical,INC. | $9.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danny Luong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.